Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases

Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases

US Patent 10947296 · Granted Mar 16, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor cells targeting ROBO1, preparation method and use ther2025
Injector pen and dose adjustment mechanism thereof2025
Lentinula edodes-derived saltiness enhancing peptide, method for preparing the s2025
Method of preparing a fusion reactor divertor component2024
Solid target system for radionuclide preparation2024
Detection kit for Salmonella typhi, preparation method and application thereof2024
Method for generating novel impedance configuration for three-degree-of-freedom 2024
Peptidomimetics for the treatment of Norovirus infection2024
Nucleotide sequences for encoding CAR, ROBO1 CAR-NK cells of expressing the CAR,2023
Nucleotide sequences for encoding CAR, ROBO1 CAR-NK cells of expressing the CAR,2023
Preparation method of biomedical titanium implant with function of eliminating s2023
Chimeric antigen receptor cells targeting ROBO1, preparation method and use ther2023